| Cellular and molecular actions of methylene blue in the nervous system M Oz, DE Lorke, M Hasan, GA Petroianu Medicinal research reviews 31 (1), 93-117, 2011 | 527 | 2011 |
| Methylene blue and Alzheimer's disease M Oz, DE Lorke, GA Petroianu Biochemical pharmacology 78 (8), 927-932, 2009 | 370 | 2009 |
| Entry of oximes into the brain: a review DE Lorke, H Kalasz, GA Petroianu, K Tekes Current medicinal chemistry 15 (8), 743-753, 2008 | 232 | 2008 |
| Nitric oxide synthase expression and role during cardiomyogenesis W Bloch, BK Fleischmann, DE Lorke, C Andressen, B Hops, J Hescheler, ... Cardiovascular research 43 (3), 675-684, 1999 | 192 | 1999 |
| Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients DE Lorke, G Lu, E Cho, DT Yew BMC neuroscience 7 (1), 36, 2006 | 150 | 2006 |
| Proliferation and apoptosis in the developing human neocortex WY Chan, DE Lorke, SC Tiu, DT Yew The Anatomical Record: An Official Publication of the American Association …, 2002 | 142 | 2002 |
| Expression of the Na-K-2Cl-cotransporter NKCC1 during mouse development CA Hübner, DE Lorke, I Hermans-Borgmeyer Mechanisms of development 102 (1-2), 267-269, 2001 | 102 | 2001 |
| Quantitative aspects of chemical carcinogenesis and tumor promotion in liver HW Kunz, HA Tennekes, RE Port, M Schwartz, D Lorke, G Schaude Environmental Health Perspectives 50, 113, 1983 | 96 | 1983 |
| CT-guided blocks and neuroablation of the ganglion impar (Walther) in perineal pain: anatomy, technique, safety, and efficacy K Agarwal-Kozlowski, DE Lorke, CR Habermann, JS Am Esch, H Beck The Clinical journal of pain 25 (7), 570-576, 2009 | 94 | 2009 |
| On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer’s disease M Oz, D E Lorke, KH S Yang, G Petroianu Current Alzheimer Research 10 (6), 618-630, 2013 | 90 | 2013 |
| Nkx6. 1 controls migration and axon pathfinding of cranial branchio-motoneurons MS Myriam Müller, Normund Jabs, Dietrich E Lork, Bernd Fritzsch Development 130 (23), 5815-5826, 2003 | 89* | 2003 |
| Diabetes and COVID-19: short-and long-term consequences C Steenblock, M Hassanein, EG Khan, M Yaman, M Kamel, M Barbir, ... Hormone and Metabolic Research 54 (08), 503-509, 2022 | 84 | 2022 |
| Entry of two new asymmetric bispyridinium oximes (K‐27 and K‐48) into the rat brain: comparison with obidoxime DE Lorke, MY Hasan, SM Nurulain, R Sheen, K Kuča, GA Petroianu Journal of Applied Toxicology: An International Journal 27 (5), 482-490, 2007 | 83 | 2007 |
| Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates. A review DE Lorke, GA Petroianu Journal of Applied Toxicology 39 (1), 101-116, 2019 | 71 | 2019 |
| In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line DE Lorke, M Krüger, R Buchert, KH Bohuslavizki, M Clausen, ... Journal of Nuclear Medicine 42 (4), 646-654, 2001 | 60 | 2001 |
| In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl‐fluorophosphate DE Lorke, MY Hasan, K Arafat, K Kuča, K Musilek, A Schmitt, ... Journal of Applied Toxicology: An International Journal 28 (4), 422-429, 2008 | 59 | 2008 |
| Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury M Oz, DE Lorke Biomedicine & Pharmacotherapy 136, 111193, 2021 | 57 | 2021 |
| Differential expression of the estrogen receptor-related receptor γ in the mouse brain DE Lorke, U Süsens, U Borgmeyer, I Hermans-Borgmeyer Molecular brain research 77 (2), 277-280, 2000 | 57 | 2000 |
| A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor M Oz, DE Lorke, N Kabbani Pharmacology & Therapeutics 221, 107750, 2021 | 55 | 2021 |
| Taschenlehrbuch Anatomie J Kirsch, CA May, D Lorke, A Winkelmann, W Schwab, G Herrmann, ... Georg Thieme Verlag, 2017 | 55 | 2017 |
Petroianu GeorgKhalifa UniversityVerified email at ku.ac.ae
